Cycl2r, your three-activity framework is accurate as far as

New Post Public Reply Private Reply Replies (1) Message Board
MGK_2 Cycl2R #162993
439
Cycl2r, your three-activity framework is accurate as far as it goes, and the question of whether there is a fourth layer, direct tumor cell destruction independent of immune priming, has a published answer worth giving you.

The short version: leronlimab does not kill tumor cells directly as a standalone cytotoxic agent. But it does something distinct from the three activities you named, and it matters.

The longer version follows.
Your three-activity framework maps correctly onto the literature. 

Anti-metastatic activity is documented in the Jiao, Wang, and Pestell 2021 Breast Cancer Research paper, showing greater than 98 percent reduction in TNBC lung metastasis in xenograft models through CCR5-dependent blockade of tumor cell extravasation and distant seeding. 

Anti-fibrotic activity is documented across three independent mouse models in the Palmer et al. hepatic fibrosis publication, with p-values of 0.0005, less than 0.0001, and 0.0006. 

PD-L1 upregulation is documented in cell culture, histology, and Rhesus monkey models from the AACR IO February 2026 presentation by Professor Jiao, with leronlimab-mediated CCR5 inhibition increasing PD-L1 and PD-1 abundance and reducing sB7-H3 and sTyro3 immune suppression mediators simultaneously.

The fourth activity layer is chemotherapy and radiation sensitization, and it is distinct from immune priming.
At the AACR Special Conference in Brain Cancer in March 2026 https://www.reddit.com/r/Livimmune/comments/1..._abstract/  , the poster presented by Ritika Harish documented that CCR5 inhibition with leronlimab demonstrated functional synergy with temozolomide, enhancing tumor cell killing in human GBM cell lines, and that pretreatment with leronlimab enhanced radiation-induced cytotoxicity. Metabolic profiling using Seahorse analysis showed that CCR5 inhibition reduced oxygen consumption rate in a dose-dependent manner, consistent with modulation of glycolytic and metabolic programs. This is not immune architecture manipulation. This is direct interference with the metabolic machinery the tumor cell uses to sustain proliferation and resist DNA damage.

The Jiao 2021 paper confirms the same pattern in TNBC: leronlimab alone did not cause significant cytotoxicity in breast cancer cell lines, but the addition of leronlimab to doxorubicin decreased cell viability and enhanced cell death across seven cell lines at p less than 0.001. The mechanism is CCR5-dependent disruption of the proliferative signaling cascade, confirmed in the June 2026 Frontiers in Immunology phosphoproteomics paper showing CCR5 knockout abolishing CEP131, KHDRBS1, and MAPK6 activation, all of which are cell cycle regulators. When those pathways are disrupted simultaneously with DNA-damaging chemotherapy or radiation, the tumor cell's repair and survival machinery is compromised at two levels at once.

So the complete framework has four confirmed activity layers: anti-metastatic through CCR5-dependent blockade of tumor cell extravasation; anti-fibrotic through CCR5-dependent stellate cell and myeloid trafficking suppression; immune priming through PD-L1 upregulation and T cell exhaustion pathway modulation; and chemotherapy and radiation sensitization through CCR5-dependent metabolic and cell cycle disruption. The fourth layer does not replace the immune priming argument. It operates alongside it and means leronlimab's contribution to tumor killing is not entirely dependent on having a functional immune system present to do the downstream work.

That is a meaningfully broader platform than three activities alone, and you identified the right question to ask.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

California Stone Ban Puts a Hidden Worker Toll in View

Updated Category News Views 42

Countertops are supposed to finish a kitchen, not quietly wreck the lungs of the people cutting them. Yet California's move toward prohibiting the fabrication and installation of artificial stone containing more than 1% crystalline silica puts an ugly, long-running occupational-health problem in plain sight. This is not a story that calls for chest-thumping market talk....

Continue Reading
Water Damage Coverage Has More Traps Than Homeowners Think

Updated Category News Views 29

A wet basement does not care one bit whether the water arrived dramatically or dripped in for months. That ugly distinction, though, can decide whether a homeowner has an insurance claim or a repair bill that lands with a thud. Kathy Thurmond-Edwards, an insurance expert in Memphis, Tennessee, lays out the dividing lines plainly: sudden pipe failures may be treated very...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 68

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Surf City Seasons Put Vacation Rental Timing in Focus

Updated Category News Views 28

Summer’s Calendar Does the Talking School bells, not seagulls, appear to set the pace for Surf City’s rental market. Chris Rackley’s seasonal guide makes a pretty grounded point: the “best” time to visit Surf City, North Carolina, is not some universal magic week on a postcard. It depends on whether a traveler needs peak beach weather, wants elbow room, or...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 71

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 73

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 110

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 61

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading

Top 5 Most Recently Viewed Articles

Organon & Co. Class Action Lawsuit: Key Details You Should Know

Updated Category News Views 221

Overview of the Class Action Lawsuit Against Organon & Co. The latest developments in the class action lawsuit regarding Organon & Co. (NYSE: OGN) have attracted attention from investors. The lawsuit is aimed at representing purchasers of Organon's publicly traded securities during a specific time frame. Robbins Geller Rudman & Dowd LLP has taken the lead in filing this...

Continue Reading
JINRO Partners with BTS's V: A Strategic Move

Updated Category News Views 25

What's Brewing Between JINRO and BTS's V? Picture this: you're wandering the aisles of an international market, see a splashy new bottle of soju, and notice V from BTS smiling from the label. That's right, folks, JINRO, the world's reigning soju brand, has just snagged a partnership with BTS's V to serve up a global brand punch. This move isn't just a pretty face on a...

Continue Reading
Latin Metals Unveils Exciting Spin-Out Plan for Copper Assets

Updated Category News Views 172

Latin Metals Moves Forward with Spin-Out of Peruvian Assets Latin Metals Inc. (TSXV: LMS, OTCQB: LMSQF) is charting a new course by announcing its decision to spin-out certain Peruvian exploration projects into a newly founded subsidiary named Latin Explore. This strategic move aims to unlock value for shareholders while maintaining a robust exploration agenda. Overview...

Continue Reading
McCormick's Resilience Shines Amidst Economic Challenges

Updated Category News Views 66

McCormick Challenges and Growth Strategy McCormick & Company, Inc. (NASDAQ: MKC) recently announced its third-quarter earnings, revealing a solid financial performance, even in a tough consumer environment. The company achieved a 1% volume growth in its Consumer segment and steady sales in its Flavor Solutions segment, showcasing a strong market presence despite...

Continue Reading
Goodyear's Financial Performance Amidst Industry Challenges

Updated Category News Views 248

Understanding Goodyear's Recent Earnings Report Goodyear Tire & Rubber Co (NASDAQ: GT) has reported its recent financial results, particularly highlighting the challenges faced during the second quarter of their fiscal year 2025. This period proved to be quite turbulent after the closing bell, reflecting considerable disruptions in their operating environment that...

Continue Reading